| Genome-wide association studies for taxane-induced peripheral neuropathy in ECOG-5103 and ECOG-1199 BP Schneider, L Li, M Radovich, F Shen, KD Miller, DA Flockhart, G Jiang, ... Clinical Cancer Research 21 (22), 5082-5091, 2015 | 138 | 2015 |
| Genetic associations with taxane-induced neuropathy by a genome-wide association study (GWAS) in E5103. BP Schneider, L Li, K Miller, D Flockhart, M Radovich, BA Hancock, ... Journal of Clinical Oncology 29 (15_suppl), 1000-1000, 2011 | 58 | 2011 |
| Genetic variant predicts bevacizumab-induced hypertension in ECOG-5103 and ECOG-2100 BP Schneider, L Li, F Shen, KD Miller, M Radovich, A O'neill, RJ Gray, ... British journal of cancer 111 (6), 1241-1248, 2014 | 50 | 2014 |
| Examining and predicting drug preferences of patients with metastatic breast cancer: using conjoint analysis to examine attributes of paclitaxel and capecitabine ML Smith, CB White, E Railey, GW Sledge Breast cancer research and treatment 145, 83-89, 2014 | 20 | 2014 |
| Tumor genomic profiling practices and perceptions: a survey of physicians participating in the NCI-match trial A Chen, K Flaherty, PJ O’Dwyer, B Giantonio, DM Marinucci, JW Lee, ... JCO precision oncology 4, 1207-1216, 2020 | 11 | 2020 |
| Discerning the clinical relevance of biomarkers in early stage breast cancer TJ Ballinger, N Kassem, F Shen, G Jiang, ML Smith, E Railey, J Howell, ... Breast cancer research and treatment 164, 89-97, 2017 | 9 | 2017 |
| Patient familiarity with, understanding of, and preferences for clinical trial endpoints and terminology MS von Itzstein, E Railey, ML Smith, CB White, GW Sledge Jr, JR Howell, ... Cancer 126 (8), 1605-1613, 2020 | 7 | 2020 |
| Examining patient choices for metastatic breast cancer drugs. ML Smith, CB White, E Railey, AM Storniolo, GW Sledge Journal of Clinical Oncology 30 (15_suppl), 6053-6053, 2012 | 5 | 2012 |
| Preferences of patients with metastatic breast cancer. ML Smith, CB White, E Railey, AM Storniolo, GW Sledge Journal of Clinical Oncology 29 (15_suppl), 6044-6044, 2011 | 5 | 2011 |
| Accessing targeted therapies: a potential roadblock to implementing precision oncology? MS von Itzstein, ML Smith, E Railey, CB White, JS Dieterich, ... JCO Oncology Practice 17 (7), e999-e1011, 2021 | 3 | 2021 |
| NGS testing use and results: A survey of US oncologists. ML Smith, E Railey, CB White, JS Dieterich, E Garrett-Mayer, ... Journal of Clinical Oncology 38 (15_suppl), e19145-e19145, 2020 | 2 | 2020 |
| Use, attitudes, and perceptions of tumor genomic testing: Survey of TAPUR physicians. SS Bruinooge, AC Dueck, SW Gray, NL Butler, CB White, ML Smith, ... Journal of Clinical Oncology 37 (15_suppl), 6531-6531, 2019 | 2 | 2019 |
| Do informed patients have different CIPN outcomes? Results of a Research Advocacy Network survey. ML Smith, CB White, E Railey, R Bellucci, C Thompson Journal of Clinical Oncology 34 (7_suppl), 60-60, 2016 | 1 | 2016 |
| Discerning clinical relevance of biomarkers in early stage breast cancer ML Smith, E Railey, CB White, BP Schneider Infection 5, 5, 2013 | 1 | 2013 |
| New insights on oncologist use of genomic testing. ML Smith, CB White, E Railey, SW Gray, DE Gerber Journal of Clinical Oncology 41 (16_suppl), e18741-e18741, 2023 | | 2023 |
| Abstract P5-15-07: Let's talk about it: Communicating about risk of recurrence in early-stage breast cancer ML Smith, EM Railey, CB White Cancer Research 82 (4_Supplement), P5-15-07-P5-15-07, 2022 | | 2022 |
| Abstract PS9-01: Consumer and patient reactions to trials of chemotherapy reductions reveal an urgent need to name and explain the concept ML Smith, E Railey, CB White, J Hill, CJ Andrews, GB Rocque Cancer Research 81 (4_Supplement), PS9-01-PS9-01, 2021 | | 2021 |
| The influence of patient engagement on the design and implementation of a clinical trial to improve cancer care delivery. S Barger, SD Sullivan, GH Lyman, DL Hershman, A Bell-Brown, ... Journal of Clinical Oncology 36 (30_suppl), 223-223, 2018 | | 2018 |
| Do informed patients have different chemotherapy-induced peripheral neuropathy outcomes? Results of research advocacy network's survey ML Smith, C White, E Railey, R Bellucci, C Thompson, C Chauhan QUALITY OF LIFE RESEARCH 25, 114-114, 2016 | | 2016 |
| What is the impact of treatments received for MBC on the ability to perform activities of daily living, symptom burden, and productivity? A Tevaarwerk, CM Reyes, HP Goertz, ML Smith, PS Bajaj, E Railey, ... Journal of Clinical Oncology 34 (15_suppl), e18118-e18118, 2016 | | 2016 |
